Refine your search

Clear

Search Results

Here are the studies that match your search criteria. If you are interested in participating, please reach out to the contact listed for the study. If no contact is listed, contact us and we'll help you find the right person.

1 Study Matches

Site for A Phase 2a, Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ATI-450 vs Placebo in Patients with Moderate to Severe Hidradenitis Suppurativa (HS)

Moderate to Severe Hidradenitis Suppurativa (HS): Placebo-Controlled (non active ingredient), 12-week treatment period. Oral medicine taken twice daily. Males/Females 18 - 70 years of age. The goal of the study is assess the efficacy (desired or intended result) of ATI-450 in patients with moderate to severe HS
Amy Longenecker at alongenecker@pennstatehealth.psu.edu or 717-531-1513
All
18 year(s) or older
This study is NOT accepting healthy volunteers
N/A
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
History of HS for at least 1 year
Must have HS lesions in 2 different areas
Exclusion Criteria:
Certain HS medications are not allowed; study coordinator will discuss
History of stroke
Positive for HIV or hepatitis B or C
Skin Conditions
  Email this study information to me
  Contact the study team
  Show all 1 locations

Study Locations

Hide all locations
Location
Hershey, PA